期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
朝鲜蓟叶中的酚性糖苷化合物(英文) 被引量:5
1
作者 刘荣 蒋孟圆 +1 位作者 周忠玉 刘吉开 《云南植物研究》 CSCD 北大核心 2009年第1期89-92,共4页
从朝鲜蓟(Cynara scolymus)叶中分离得到2个酚性糖苷化合物,其中一个是新化合物,通过波谱学方法确定其结构为2-甲氧基-4-(2,3-二羟基-丙酰基)-苯基-1-O-(6′-O-没食子酰基)-β-D-吡喃葡萄糖苷(1)。
关键词 朝鲜蓟 菊科 酚性糖苷
原文传递
马醉木叶的酚性化学成分(英文) 被引量:8
2
作者 姚广民 王玉波 +1 位作者 汪礼权 秦国伟 《药学学报》 CAS CSCD 北大核心 2008年第3期284-290,共7页
为了研究马醉木(Pieris japonica)叶的化学成分,采用各种色谱方法对其乙醇提取物进行分离,所得成分用各种波谱特别是一维和二维NMR进行结构测定,最后分离鉴定出8种酚性成分(1-8),其中erythrosyringoylglycerol 4-O-β-D-glucos... 为了研究马醉木(Pieris japonica)叶的化学成分,采用各种色谱方法对其乙醇提取物进行分离,所得成分用各种波谱特别是一维和二维NMR进行结构测定,最后分离鉴定出8种酚性成分(1-8),其中erythrosyringoylglycerol 4-O-β-D-glucoside(1)、1-(2-β-D-glucopyranoxyl-4-methoxyl-6-hydroxyphenyl)-3-hydroxyl-1-propanone(3)、erythro-1-(4-hydroxyl-3-methoxyphenyl)-2-[4-(3-β-D—glucopyranoxypropyl)-2,6-dimethoxyphenoxy]-1,3-propanediol(4)为3种新化合物,其余5种已知化合物syringoylglycerol 8-O-β-D—glucoside(2)、magnoleninC(5)、syringaresinolmono-β-D-glucoside(6)、3-(4-hydroxyl-3-methyphenyl)-1-propanol-1-O-β-D—glucoside(7)和3,5-dimethoxyl-4-hydroxybenzylalcohol4-O-β-D—glucoside(8)为该植物中首次报道,化合物1和2在体外试验中显著抑制T和B细胞的增殖。 展开更多
关键词 马醉木 杜鹃花科 糖苷 免疫抑制活
下载PDF
Preparation and characterization of drop pills of effective part from safflower for anti-Parkinson's disease 被引量:2
3
作者 Shixuan Cheng Yingcong Ma +10 位作者 Yujie Liu Ning Pang Ji Li Meng Sha Rutong Ren Nuramatjan Ablat Jing Cao Yi Sun Xiaoping Pu Min Ye Xianrong Qi 《Journal of Chinese Pharmaceutical Sciences》 CAS CSCD 2019年第1期27-39,共13页
Parkinson’s disease(PD) is a common degenerative disease of the central nervous system, and the pathologic features are mainly degeneration of substantianigra and dopamine neurons. Studies have shown that safflower f... Parkinson’s disease(PD) is a common degenerative disease of the central nervous system, and the pathologic features are mainly degeneration of substantianigra and dopamine neurons. Studies have shown that safflower flavonoid extract(SAFE) exhibits the neuroprotective effect. In this study, the safflower flavonoid extract drop pills(SAFE-DPs) for anti-PD were prepared by the heating and melting method using SAFE and matrix PEG6000. The performances of the pills were evaluated with powder X-ray diffraction(PXRD), differential scanning calorimetry(DSC), Fourier transform infrared spectroscopy(FT-IR), scanning electron microscopy(SEM) and dissolution testing. The analysis results demonstrated an amorphous state for SAFE dispersion in the matrix PEG6000 without any chemical reaction. The SAFE-DPs demonstrated acceptable chemical and physical stability irrespective of the manufacturing process and the storage period. Dissolution testing in three dissolution media(pH 1.0, pH 6.8 and pH 7.5) indicated that SAFE-DPs had excellent dissolution property. The transport of Kaempferol-3-rutinoside(K3 R) on the Caco-2 monolayer and the absorption of K3 R in situ intestinal perfusion revealed that the principal component of SAFE had a good transport and absorption capacity. Therefore, the drop pills had better release and absorption in the gastrointestinal tract, corresponding with the pharmacological and pharmacodynamic results for PD in vivo. 展开更多
关键词 Safflower flavonoid extract Parkinson’s disease Solid dispersion Drop pills Kaempferol-3-O-rutinoside CHARACTERIZATIONS
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部